April 24, 2020 / By Erika Edwards The Food and Drug Administration on Friday cautioned against prescribing hydroxychloroquine to COVID-19 patients outside of hospital settings or clinical trials. The drug, an antimalarial, was repeatedly touted by President Donald Trump as a possible treatment for the coronavirus. “The FDA is aware of reports of serious heart rhythm …